Qualigen Therapeutics IncChange company Symbol lookupSelect an option...QLGN Qualigen Therapeutics IncCHEA Chenghe Acquisition CoCRIS Curis IncPIXY ShiftPixy IncRVLP RVL Pharmaceuticals PLCNAUT Nautilus Biotechnology IncBOF BranchOut Food IncSPRC Scisparc LtdNRSN Neurosense Therapeutics LtdACNT Ascent Industries CoGo
Qualigen Therapeutics, Inc. is a diversified life sciences company. The Company is focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics. Its cancer therapeutics pipeline includes QN-302, RAS and QN-247. QN-302 is a small molecule genomic quadruplex (G4) selective transcription inhibitor with a strong binding affinity to G4s prevalent in cancer cells. RAS is a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules for preventing mutated RAS genes’ proteins from binding to their effector proteins; preventing this binding could stop tumor growth, especially in RAS-driven tumors such as pancreatic, colorectal and lung cancers. QN-247 is a deoxyribonucleic acid (DNA) coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer, including triple negative breast cancer, acute myeloid leukemia (AML) and glioblastoma.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
- Prev Close
- 0.9801
- Today's Open
- 0.97
- Day's Range
- 0.97-1.03
- Avg Vol (10-day)
- 8.6K
- Last (time)
- 3:59p ET 09/29/23
- Last (size)
- 60
- 52-Wk Range
0.83 - 3.24- LowHigh
- 52-Wk Range
% Above Low
The current share price compared to the 52-week low.
- 21.69%
- Historical Volatility
Historical Volatility
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
- 73.0%
- Market Cap
- 5.1M
- Shares Outstanding
- 5.1M
- EPS (TTM, GAAP)
EPS (TTM, GAAP)
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- -3.94
- P/E Ratio (TTM, GAAP)
P/E Ratio (TTM, GAAP)
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- --
- Annual Dividend/Yield
Annual Dividend/Yield
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
- No dividend
- Ex-dividend Date
- No dividend
- Dividend Pay Date
- No dividend
- Beta
Beta
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
- -0.4
- % Held by Institutions
% Held by Institutions
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
- 2.02
- Short Interest(% of float 09/15/23)
Short Interest
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
- 0.80
Latest News
| September 27, 2023 | |
|---|---|
| 8:30 am ET | |
| Globe Newswire | |
| August 17, 2023 | |
| 8:30 am ET | |
| Globe Newswire | |
| August 15, 2023 | |
| 8:30 am ET | |
| Globe Newswire | |
| August 01, 2023 | |
| 8:30 am ET | |
| Globe Newswire | |
| July 24, 2023 | |
| 8:15 am ET | |
| Globe Newswire | |
| Go to all current & historical news | |
Events
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.